Form 4: Phathom Pharma Exec Reports Stock Transactions

Phathom Pharmaceuticals' Chief Legal Officer, Anne Marie Cook, reported the acquisition of shares from vested performance units and the disposition of shares for tax withholding.

Summary

• Anne Marie Cook, Chief Legal Officer and Corporate Secretary of Phathom Pharmaceuticals, Inc., reported changes in her beneficial ownership of common stock.
• On February 10, 2026, she acquired 3,461 shares of common stock upon the vesting of performance stock units granted on June 23, 2025, based on achieved performance criteria.
• Concurrently, she disposed of 1,535 shares of common stock at a price of $12.82 per share to satisfy tax withholding obligations related to the PSU vesting.
• Her beneficial ownership following these reported transactions is 88,660 shares.
• The reported beneficial ownership also includes 1,722 shares acquired under the Phathom Pharmaceuticals, Inc. employee stock purchase plan in January 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, representing routine insider transactions related to executive compensation and tax obligations, which is common practice.

Positives

• The vesting of 3,461 performance stock units indicates that specific performance criteria, determined on February 10, 2026, were successfully met. This suggests positive operational or financial achievements by Phathom Pharmaceuticals, Inc.

Negatives

• The disposition of 1,535 shares for tax withholding is a standard practice associated with the vesting of equity awards and does not inherently reflect a negative outlook or event.

Future Outlook

This filing does not contain forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that routine insider transactions, such as those reported in a Form 4, are common across the pharmaceutical industry as a mechanism for executive compensation and tax management related to equity awards. These transactions typically do not signal broader industry trends or competitive shifts.

Stakeholder Impact

• Shareholders: The vesting of performance stock units indicates that management has met certain performance targets, which could be viewed positively. The disposition for tax withholding is a routine event with minimal impact.
• Employees: The mention of an employee stock purchase plan (ESPP) indicates a benefit available to employees, fostering alignment with company performance.

Key Dates

Keywords

Phathom Pharmaceuticals, PHAT, Insider Trading, Form 4, Stock Transaction, Performance Stock Units, Equity Compensation, Executive Compensation